Ferroptosis has emerged as one of the most intensely studied forms of regulated cell death in the past decade. Unlike apoptosis (programmed cell death through caspase activation) or necroptosis (inflammatory cell death through RIPK/MLKL signaling), ferroptosis is driven by the catastrophic accumulation of iron-dependent lipid peroxides in cellular membranes. When the protective systems that normally neutralize these peroxides fail, membrane integrity collapses and the cell dies.
What makes ferroptosis so compelling for researchers is its intersection with cancer biology, immunology, and drug resistance. Cancer cells with high iron uptake, altered lipid metabolism, or defective antioxidant defenses are selectively vulnerable to ferroptosis – and importantly, drug-resistant cancer cells that have evaded apoptosis often remain susceptible to ferroptotic cell death. This has positioned ferroptosis as a potential strategy for overcoming resistance to conventional chemotherapy and targeted therapies.
The Core Ferroptosis Machinery
Understanding which compounds to use requires understanding the pathway they target. Ferroptosis regulation centers on a critical balance between lipid peroxide generation and lipid peroxide detoxification:
The System Xc-/GSH/GPX4 axis is the primary defense against ferroptosis. System Xc- (the cystine/glutamate antiporter, with SLC7A11 as its catalytic subunit) imports cystine into the cell, which is reduced to cysteine and used to synthesize glutathione (GSH). GSH serves as the essential cofactor for GPX4 (glutathione peroxidase 4), the only enzyme in the mammalian cell that directly reduces phospholipid hydroperoxides within intact membranes. When any component of this axis is inhibited – cystine import blocked, GSH depleted, or GPX4 inactivated – lipid peroxides accumulate and ferroptosis proceeds.
Iron and lipid metabolism supply the substrates for lipid peroxide generation. Free intracellular iron catalyzes Fenton chemistry, generating reactive oxygen species that attack polyunsaturated fatty acids (PUFAs) in membrane phospholipids. Enzymes like ACSL4 (which incorporates PUFAs into membranes) and LPCAT3 (which remodels membrane phospholipid composition) determine how much “fuel” is available for ferroptotic lipid peroxidation.
Key Ferroptosis-Inducing Compounds
System Xc- Inhibitors (Indirect GPX4 Suppression)
Erastin is the founding ferroptosis inducer – the compound that put ferroptosis on the map. It inhibits System Xc-, blocking cystine uptake and starving the cell of the raw material needed to synthesize GSH. Without GSH, GPX4 cannot function, and lipid peroxides accumulate to lethal levels. Erastin-class compounds are widely used as positive controls for ferroptosis induction in cell-based assays. Immunomart stocks erastin analogs and related System Xc- inhibitors through its cell death compound collection.
Sulfasalazine and sorafenib also inhibit System Xc- activity, though through distinct mechanisms. Sorafenib, in particular, has dual activity as both a multi-kinase inhibitor and a ferroptosis inducer – a property that contributes to its efficacy in hepatocellular carcinoma research models.
Direct GPX4 Inhibitors
RSL3 (RAS-selective lethal 3) directly and covalently inhibits GPX4 by binding to its active-site selenocysteine residue. This is the most widely used direct GPX4 inhibitor in ferroptosis research. Unlike erastin, which works upstream by depleting GSH, RSL3 shuts down the final protective enzyme directly, making it a more potent and rapid ferroptosis inducer. RSL3 is available from Immunomart for laboratory research.
ML162 is an alternative covalent GPX4 inhibitor with a different chemical scaffold, useful as a confirmatory tool compound when establishing that an observed effect is GPX4-dependent rather than RSL3-specific. ML162-yne (an alkyne-tagged analog for click chemistry applications) is available for advanced target engagement studies.
GPX4-IN-16 and other next-generation GPX4 inhibitors (available from Immunomart) offer improved selectivity profiles for researchers requiring more refined pharmacological tools.
Iron Metabolism Modulators
FIN56 promotes GPX4 degradation while simultaneously depleting CoQ10, attacking two independent lipid peroxide defense systems at once. It is mechanistically distinct from both erastin and RSL3 and is valuable for confirming ferroptosis through an orthogonal mechanism.
Key Ferroptosis Inhibitors (Rescue Compounds)
Every ferroptosis study needs rescue controls – compounds that block ferroptosis to confirm that the cell death you observe is genuinely ferroptotic rather than apoptotic or necrotic.
Ferrostatin-1 (Fer-1) is the gold-standard ferroptosis inhibitor. It is a radical-trapping antioxidant that specifically quenches lipid peroxyl radicals in membranes, blocking the chain reaction of lipid peroxidation. If cell death is rescued by Fer-1 but not by caspase inhibitors (zVAD-FMK) or necroptosis inhibitors (necrostatin-1), you can confidently classify it as ferroptosis. Ferrostatin-1 diyne and SRS16-86 (an improved ferrostatin analog with better metabolic stability) are available from Immunomart.
Liproxstatin-1 is another lipid peroxidation inhibitor with in vivo applicability. Liproxstatin-1 hydrochloride and its analog are available for both in vitro and in vivo ferroptosis rescue experiments.
Deferoxamine (DFO) is an iron chelator that blocks ferroptosis by removing the free iron required for Fenton chemistry. Rescue by DFO confirms the iron-dependence of the observed cell death.
Designing a Ferroptosis Experiment: Essential Controls
A well-controlled ferroptosis experiment typically includes:
Induction: Erastin (System Xc- inhibition) or RSL3 (direct GPX4 inhibition), or both for mechanistic comparison.
Ferroptosis rescue: Ferrostatin-1 or Liproxstatin-1 (lipid peroxidation inhibitor) and Deferoxamine (iron chelator). Rescue by both classes confirms ferroptotic cell death.
Negative rescue controls: zVAD-FMK (caspase inhibitor – should NOT rescue ferroptosis) and Necrostatin-1 (RIPK1 inhibitor – should NOT rescue ferroptosis).
Readouts: Lipid peroxidation (C11-BODIPY 581/591 fluorescent probe), GSH levels, and cell viability (CCK-8, PI staining).
Browse Ferroptosis Research Compounds
Immunomart’s cell death research collection from Targetmol includes ferroptosis inducers, inhibitors, and pathway modulators. Browse GPX4 inhibitors, System Xc- blockers, iron metabolism tools, and lipid peroxidation probes. Each product page includes structure, purity, activity data, and published references.
Disclaimer: All products referenced are for laboratory research use only (RUO). Not for human or animal consumption, diagnostic, or therapeutic use. Immunomart supplies research-grade compounds for in vitro and in vivo laboratory studies.
